United States Food and Drug Administration (USFDA) has completed inspection at Jubilant Pharmova’s subsidiary -- Jubilant Cadista Pharmaceuticals Inc., (Jubilant Cadista)’s solid oral formulations facility at Salisbury, Maryland.
USFDA has issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time. Going forward, the said facility is not expected to manufacture any products as it has closed manufacturing operations as was referenced in the previous disclosure dated April 18, 2024.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
